Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

The American Journal of Pathology - Tập 163 Số 5 - Trang 2113-2126 - 2003
Elaine Y. Lin1, Joan G. Jones2, Ping Li3, Liyin Zhu3, Kathleen D. Whitney2, William J. Muller4, Jeffrey W. Pollard3
1Center for Study of Reproductive Biology and Women's Health, Departments of Developmental and Molecular Biology/Obstetrics and Gynecology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
2Department of Pathology, Albert Einstein College of Medicine, Bronx, New York
3Center for Study of Reproductive Biology and Women's Health and the Departments of Developmental and Molecular Biology and Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York
4Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Greenlee, 2000, Cancer statistics, 2000, CA Cancer J Clin, 50, 7, 10.3322/canjclin.50.1.7

Lakhani, 1999, The transition from hyperplasia to invasive carcinoma of the breast, J Pathol, 187, 272, 10.1002/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2

Merlino, 1994, Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice, Semin Cancer Biol, 5, 13

Green, 2000, The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma, Oncogene, 19, 1020, 10.1038/sj.onc.1203280

Furth, 1998, SV40 rodent tumour models as paradigms of human disease: transgenic mouse models, Dev Biol Stand, 94, 281

Macleod, 1999, Insights into cancer from transgenic mouse models, J Pathol, 187, 43, 10.1002/(SICI)1096-9896(199901)187:1<43::AID-PATH246>3.0.CO;2-P

Lin, 2001, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J Exp Med, 193, 727, 10.1084/jem.193.6.727

Guy, 1992, Induction of mammary tumors by expression of polyomovirus middle T oncogenes: a transgenic mouse model of a metastatic disease, Mol Cell Biol, 12, 954, 10.1128/MCB.12.3.954

Dankort, 2000, Signal transduction in mammary tumorigenesis: a transgenic perspective, Oncogene, 19, 1038, 10.1038/sj.onc.1203272

Asch, 1996, Tumor viruses and endogenous retrotransposons in mammary tumorigenesis, J Mammary Gland Biol Neoplasia, 1, 49, 10.1007/BF02096302

Dawe, 1987, Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles, Am J Pathol, 127, 243

Brison, 1993, Gene amplification and tumor progression, Biochim Biophys Acta, 1155, 25

Lapidus, 1998, The loss of estrogen and progesterone receptor gene expression in human breast cancer, J Mammary Gland Biol Neoplasia, 3, 85, 10.1023/A:1018778403001

Menard, 2000, Role of HER2 gene overexpression in breast carcinoma, J Cell Physiol, 182, 150, 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E

Bieche, 1995, Genetic alterations in breast cancer, Genes Chromosom Cancer, 14, 227, 10.1002/gcc.2870140402

Bissell, 2002, The organizing principle: microenvironmental influences in the normal and malignant breast, Differentiation, 70, 537, 10.1046/j.1432-0436.2002.700907.x

Nguyen, 2002, Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth, Dev Biol, 247, 11, 10.1006/dbio.2002.0669

Tong, 1999, Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E, A-cdk2 kinase activation and cell proliferation in uterine epithelial cells in mice, Mol Cell Biol, 19, 2252, 10.1128/MCB.19.3.2251

Gouon-Evans, 2000, Postnatal mammary gland development requires macrophages and eosinophils, Development, 127, 2269, 10.1242/dev.127.11.2269

Sambrook, 1989

Cardiff, 2000, The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting, Oncogene, 19, 968, 10.1038/sj.onc.1203277

Richert, 2000, An atlas of mouse mammary gland development, J Mammary Gland Biol Neoplasia, 5, 227, 10.1023/A:1026499523505

Howard, 2000, Human breast development, J Mammary Gland Biol Neoplasia, 5, 119, 10.1023/A:1026487120779

Mallon, 2000, The basic pathology of human breast cancer, J Mammary Gland Biol Neoplasia, 5, 139, 10.1023/A:1026439204849

Gouon, 2002, Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development, Breast Cancer Res, 4, 155, 10.1186/bcr441

Neville, 2002, Hormonal regulation of mammary differentiation and milk secretion, J Mammary Gland Biol Neoplasia, 7, 49, 10.1023/A:1015770423167

Shyamala, 1999, Progesterone signaling and mammary gland morphogenesis, J Mammary Gland Biol Neoplasia, 4, 89, 10.1023/A:1018760721173

Roskelley, 2002, The dominance of the microenvironment in breast and ovarian cancer, Semin Cancer Biol, 12, 97, 10.1006/scbi.2001.0417

Blackshear, 2001, Genetically engineered rodent models of mammary gland carcinogenesis: an overview, Toxicol Pathol, 29, 105, 10.1080/019262301301418919

Black, 1972, Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer, Cancer, 29, 338, 10.1002/1097-0142(197202)29:2<338::AID-CNCR2820290212>3.0.CO;2-U

Dupont, 1985, Risk factors for breast cancer in women with proliferative breast disease, N Engl J Med, 312, 146, 10.1056/NEJM198501173120303

Betsill, 1978, Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone, JAMA, 239, 1863, 10.1001/jama.1978.03280450035020

Couch, 1997, BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer, N Engl J Med, 336, 1409, 10.1056/NEJM199705153362002

Xu, 1999, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, Nat Genet, 22, 37, 10.1038/8743

Buckley, 1993, Expression and amplification of cyclin genes in human breast cancer, Oncogene, 8, 2127

Matsui, 1990, Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice, Cell, 61, 1147, 10.1016/0092-8674(90)90077-R

Andres, 1987, Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice, Proc Natl Acad Sci USA, 84, 1299, 10.1073/pnas.84.5.1299

Sandgren, 1995, Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice, Cancer Res, 55, 3915

Tsukamoto, 1988, Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice, Cell, 55, 619, 10.1016/0092-8674(88)90220-6

Maroulakou, 1994, Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene, Proc Natl Acad Sci USA, 91, 11236, 10.1073/pnas.91.23.11236

Russo, 1998, Role of hormones in mammary cancer initiation and progression, J Mammary Gland Biol Neoplasia, 3, 49, 10.1023/A:1018770218022

Jamerson, 2000, Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models, Oncogene, 19, 1065, 10.1038/sj.onc.1203268

Li, 2000, Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer, Oncogene, 19, 1002, 10.1038/sj.onc.1203273

Maglione, 2001, Transgenic polyoma middle-T mice model premalignant mammary disease, Cancer Res, 61, 8298

Sapi, 1999, The role of CSF-1 in normal and neoplastic breast physiology, Proc Soc Exp Biol Med, 220, 1, 10.3181/00379727-220-44337

Leek, 2002, Tumor-associated macrophages in breast cancer, J Mammary Gland Biol Neoplasia, 7, 177, 10.1023/A:1020304003704